HighVista Strategies’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-25,287
| Closed | -$389K | – | 138 |
|
|
2024
Q3 | $389K | Sell |
25,287
-591
| -2% | -$9.09K | 0.13% | 139 |
|
|
2024
Q2 | $421K | Buy |
+25,878
| New | +$421K | 0.15% | 120 |
|
|
2023
Q4 | – | Sell |
-18,172
| Closed | -$379K | – | 127 |
|
|
2023
Q3 | $379K | Sell |
18,172
-10,619
| -37% | -$221K | 0.18% | 126 |
|
|
2023
Q2 | $690K | Sell |
28,791
-26,783
| -48% | -$641K | 0.32% | 92 |
|
|
2023
Q1 | $1.05M | Sell |
55,574
-1,044
| -2% | -$19.6K | 0.85% | 35 |
|
|
2022
Q4 | $901K | Buy |
56,618
+3,300
| +6% | +$52.5K | 0.54% | 51 |
|
|
2022
Q3 | $872K | Buy |
53,318
+13,418
| +34% | +$219K | 0.5% | 49 |
|
|
2022
Q2 | $562K | Buy |
39,900
+5,784
| +17% | +$81.5K | 0.34% | 71 |
|
|
2022
Q1 | $826K | Buy |
+34,116
| New | +$826K | 0.53% | 55 |
|
|
2021
Q2 | – | Sell |
-16,590
| Closed | -$428K | – | 117 |
|
|
2021
Q1 | $428K | Buy |
16,590
+2,246
| +16% | +$57.9K | 0.32% | 73 |
|
|
2020
Q4 | $767K | Buy |
14,344
+1,915
| +15% | +$102K | 0.49% | 49 |
|
|
2020
Q3 | $513K | Buy |
12,429
+3,635
| +41% | +$150K | 0.37% | 47 |
|
|
2020
Q2 | $426K | Buy |
+8,794
| New | +$426K | 0.35% | 44 |
|